People In Brief
This article was originally published in The Tan Sheet
Executive Summary
Former FDA Chief Counsel Tyler joins Venable; Perrigo appoints de Velarde as regulatory affairs manager; USP shakes up its executive team; Neutra Corp. names Morrissey president and CEO; more people in brief
You may also be interested in...
Tyler's Departure As FDA Chief Counsel Leaves Another Chair To Fill
Ralph Tyler is leaving FDA 18 months after taking the helm as the agency's chief counsel.
US FDA Gene Therapy Accelerated Approval Guidance Will Describe ‘Buckets’ Of Use Scenarios
Forthcoming guidance is expected to describe areas of “low-hanging fruit” and those that are more challenging for use of the expedited pathway, Center for Biologics Evaluation and Research Director Peter Marks said.
FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Kahn Says
The agency is also poised to announce another development in its scrutiny of the drug patents listed in the FDA’s Orange Book.